AbbVie Adds IBD Candidate In Deal With China’s FutureGen

 
• By Joseph Haas
  
Next gen
FutureGen's bispecific might offer better efficacy, less frequent dosing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business